Comparison of Lung Expansion After Uniportal and Multiportal Video Assisted Thoracic Surgery for Stage II Post Pneumonic Bacterial Empyema Thoracis
NCT ID: NCT07137507
Last Updated: 2025-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2023-04-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Feasibility and Advantages of Subxiphoid Uniportal Video-assisted Thoracoscopic Surgery in Pulmonary Lobectomy
NCT03051438
Thoracoscopic Exploration in Comparison to Exploratory Thoracotomy in Chest Trauma
NCT05991570
Uniportal VATS Versus Chest Tube for Early Empyema
NCT06325904
The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
NCT07167823
A Study Investigating Pain Following Single-port or Multi-port Video Assisted Thoracoscopic Surgery
NCT02556970
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Uniportal and multiportal VATS are a feasible technique in all patients with pleural empyema requiring surgery. In this study, the investigators observed comparable postoperative success rates, no need for conversion, and successful completion of decortication via both multiportal and uniportal approaches. This transition to a single-incision technique was associated with fewer chest tubes, minimal surgical trauma, and no compromise in clinical outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uniportal Group
Uniportal Video Assisted Thoracic Surgery group
Uniportal VATS
Decortication of pleural empyema is done using single-port VATS
Multiportal Group
Multi-portal Video Assisted Thoracic Surgery group
Multi-portal VATS
Decortication of pleural empyema is done using two or more ports with VATS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Uniportal VATS
Decortication of pleural empyema is done using single-port VATS
Multi-portal VATS
Decortication of pleural empyema is done using two or more ports with VATS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* More than 18 years old patients deemed fit for intervention.
* Both genders
* Unintubated patients
Exclusion Criteria
* Patient with TB empyema
* Patient with Fungal empyema
* Patients unfit for general anesthesia.
* Unwilling to participate
18 Years
73 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Health Sciences Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zeeshan Sarwar
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Shoaib Nabi
Role: STUDY_CHAIR
SIMS, Services Hospital, Lahore
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Services Institute Of Medical Sciences, Services Hospital
Lahore, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB/2021/873/SIMS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.